Abstract
Beta-adrenocepetor antagonists (beta-blockers) alter the nanostructure of lysozyme amyloids, resulting in different drug release profiles.
Original language | English |
---|---|
Pages (from-to) | 5082-5084 |
Journal | Chemical Communications |
Volume | 49 |
Issue number | 44 |
Early online date | 23 Apr 2013 |
DOIs | |
Publication status | Published - 04 Jun 2013 |
Externally published | Yes |
ASJC Scopus subject areas
- Catalysis
- Electronic, Optical and Magnetic Materials
- Ceramics and Composites
- General Chemistry
- Surfaces, Coatings and Films
- Metals and Alloys
- Materials Chemistry